Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-07-01
1976-05-25
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, 2602405, A61K 4300, C09B 2308
Patent
active
039594556
ABSTRACT:
The method of labeling indocyanine green (ICG) with carrier-free iodine-123 comprising the steps of condensing xenon-123 on crystals of ICG followed by permitting decay of the .sup.123 Xe a sufficient length of time to produce .sup.123 I-electronically excited ions and atoms which subsequently label ICG.
REFERENCES:
chrostowski, Chemical Abstracts, Vol. 73, No. 21, Nov. 23, 1970, p. 179, Abstract No. 107396t.
Reuter et al., Chemical Abstracts, Vol. 72, No. 5, Feb. 2, 1970, p. 145, Abstract No. 19953w.
Bassir et al., Chemical Abstracts, Vol. 81, No. 23, Dec. 9, 1974, p. 211, Abstract No. 148071s.
Mikulecky et al., Chemical Abstracts, Vol. 77, No. 9, Aug. 28, 1972, pp. 308-309, Abstract No. 59607w.
Ansari Azizullah N.
Lambrecht Richard M.
Redvanly Carol S.
Wolf Alfred P.
Belkin Leonard
Carlson Dean E.
Nucker Christine M.
Padgett Benjamin R.
The United States of America as represented by the United States
LandOfFree
Labeling of indocyanine green with carrier-free iodine-123 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Labeling of indocyanine green with carrier-free iodine-123, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Labeling of indocyanine green with carrier-free iodine-123 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-906217